| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 2,803 | 7,622 | 3,277 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 2,803 | 7,622 | 3,277 | | | Operating Expenses | | Research Development | 53,664 | 54,624 | 41,234 | | Selling General and Administrative | 16,183 | 15,837 | 9,403 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (67,044) | (62,839) | (47,360) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,116 | 26,244 | 16,125 | | Earnings Before Interest And Taxes | (61,928) | (36,595) | (31,235) | | Interest Expense | 93 | 102 | 130 | | Income Before Tax | (62,021) | (36,697) | (31,365) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (62,021) | (36,697) | (31,365) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (62,021) | (36,697) | (31,365) | | Preferred Stock And Other Adjustments |
-
| (9,081) |
-
| | | Net Income Applicable To Common Shares | ($62,021) | ($45,778) | ($31,365) |
|
1.48% Nasdaq 
Income Statement
